Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma
在白血病性皮肤T细胞淋巴瘤中,通过直接或上游激酶靶向阻断STAT3/5
期刊:EMBO Molecular Medicine
影响因子:9
doi:10.15252/emmm.202115200
Helena Sorger # ,Saptaswa Dey # ,Pablo Augusto Vieyra-Garcia ,Daniel Pölöske ,Andrea R Teufelberger ,Elvin D de Araujo ,Abootaleb Sedighi ,Ricarda Graf ,Benjamin Spiegl ,Isaac Lazzeri ,Till Braun ,Ines Garces de Los Fayos Alonso ,Michaela Schlederer ,Gerald Timelthaler ,Petra Kodajova ,Christine Pirker ,Marta Surbek ,Michael Machtinger ,Thomas Graier ,Isabella Perchthaler ,Yi Pan ,Regina Fink-Puches ,Lorenzo Cerroni ,Jennifer Ober ,Moritz Otte ,Jana D Albrecht ,Gary Tin ,Ayah Abdeldayem ,Pimyupa Manaswiyoungkul ,Olasunkanmi O Olaoye ,Martin L Metzelder ,Anna Orlova ,Walter Berger ,Marion Wobser ,Jan P Nicolay ,Fiona André ,Van Anh Nguyen ,Heidi A Neubauer ,Roman Fleck ,Olaf Merkel ,Marco Herling ,Ellen Heitzer ,Patrick T Gunning ,Lukas Kenner ,Richard Moriggl ,Peter Wolf
免疫/内分泌
信号转导
T细胞
淋巴瘤
细胞生物学
JAK/STAT
白血病
STAT3
T细胞